Modis Therapeutics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $246M

Modis Therapeutics General Information

Description

Operator of a biopharmaceutical company intended to develop disease-modifying therapies for rare genetic diseases with a high unmet medical need. The company's therapeutics are under clinical development and focuses on treating thymidine kinase 2 deficiency (TK2d), an inherited mitochondrial disease, enabling medical professionals to improve nucleotide balance, increases mtDNA copy number, cell function and prolongs life.

Contact Information

Website
www.modistx.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 409 13th Street
  • Suite 700
  • Oakland, CA 94612
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 409 13th Street
  • Suite 700
  • Oakland, CA 94612
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Modis Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 09-Sep-2019 $246M Completed Generating Revenue
2. Early Stage VC (Series A) 01-Oct-2018 Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Modis Therapeutics’s complete valuation and funding history, request access »

Modis Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2
Series A1
To view Modis Therapeutics’s complete cap table history, request access »

Modis Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company intended to develop disease-modifying therapies for rare genetic diseases with a
Drug Discovery
Oakland, CA

Vancouver, Canada
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Modis Therapeutics Competitors (65)

One of Modis Therapeutics’s 65 competitors is viDA Therapeutics, a Venture Capital-Backed company based in Vancouver, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
viDA Therapeutics Venture Capital-Backed Vancouver, Canada
NGM Biopharmaceuticals Private Equity-Backed South San Francisco, CA
Regenerx Formerly VC-backed Rockville, MD
GeneCast Biotechnology Private Equity-Backed Wuxi, China
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
You’re viewing 5 of 65 competitors. Get the full list »

Modis Therapeutics Patents

Modis Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2021034962-A1 Polymorphic forms of deoxycytidine, compositions comprising the same and uses Inactive 19-Aug-2019
JP-2021521210-A A prodrug of deoxynucleosides for the treatment of diseases caused by an imbalanced nucleotide pool Active 12-Apr-2018
WO-2019200340-A1 Prodrugs of deoxynucleosides for treatment of diseases cased by unbalanced nucleotide pools Inactive 12-Apr-2018 A61K31/7076

Modis Therapeutics Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aceras BioMedical Venture Capital Minority
Downstate's Biotechnology Incubator Accelerator/Incubator
F-Prime Venture Capital Minority
OrbiMed Growth/Expansion Minority
Osage University Partners Venture Capital Minority
To view Modis Therapeutics’s complete investors history, request access »

Modis Therapeutics FAQs

  • When was Modis Therapeutics founded?

    Modis Therapeutics was founded in 2016.

  • Where is Modis Therapeutics headquartered?

    Modis Therapeutics is headquartered in Oakland, CA.

  • What industry is Modis Therapeutics in?

    Modis Therapeutics’s primary industry is Drug Discovery.

  • Is Modis Therapeutics a private or public company?

    Modis Therapeutics is a Private company.

  • What is the current valuation of Modis Therapeutics?

    The current valuation of Modis Therapeutics is .

  • What is Modis Therapeutics’s current revenue?

    The current revenue for Modis Therapeutics is .

  • How much funding has Modis Therapeutics raised over time?

    Modis Therapeutics has raised $30M.

  • Who are Modis Therapeutics’s investors?

    Aceras BioMedical, Downstate's Biotechnology Incubator, F-Prime, OrbiMed, and Osage University Partners have invested in Modis Therapeutics.

  • Who are Modis Therapeutics’s competitors?

    viDA Therapeutics, NGM Biopharmaceuticals, Regenerx, GeneCast Biotechnology, and Inovio Pharmaceuticals are some of the 65 competitors of Modis Therapeutics.

  • When was Modis Therapeutics acquired?

    Modis Therapeutics was acquired on 09-Sep-2019.

  • Who acquired Modis Therapeutics?

    Modis Therapeutics was acquired by Zogenix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process